Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050

Table 2 Breakdown of different costs per diagnosed type 2 diabetes patient in the Singapore female working-age population by age group from 2010 to 2050 (in USD)

Year	Age group	Diabetes population	Indirect productivity loss					Total economic cost^a
Year	Age group	Diabetes population	Absenteeism	Presenteeism	Diabetes-related non-participation	Lost capacity from premature mortality	Total indirect cost	Total economic cost^a
2010	20–29	1,451	122	1,313	-	-	1,435	2,931
	30–39	5,286	157	1,693	-	430	2,280	3,776
	40–49	13,520	119	1,285	-	1,572	2,976	4,472
	50–59	21,367	66	714	568	1,758	3,106	4,602
	60–69	18,956	19	210	85	1,115	1,429	2,925
2030	20–29	2,028	182	1,955	-	-	2,137	3,633
	30–39	6,954	234	2,521	-	577	3,332	4,828
	40−49	14,073	177	1,911	-	1,855	3,943	5,439
	50–59	24,739	97	1,046	853	2,123	4,118	5,614
	60–69	39,338	27	291	83	1,288	1,689	3,185
2050	20–29	2,180	273	2,937	-	-	3,210	4,706
	30–39	7,957	348	3,746	-	641	4,735	6,231
	40–49	17,070	264	2,840	-	2,007	5,110	6,606
	50–59	29,813	145	1,562	1,247	2,073	5,028	6,524
	60–69	41,261	41	436	144	1,494	2,115	3,611

^aTotal economic cost = Total indirect cost + Excess direct medical cost of US$1,496.03

ISSN: 1471-2458